IDXX | IDEXX Laboratories, Inc.

IndexNDX, S&P 500 P/E56.66 EPS (ttm)8.31 Insider Own0.30% Shs Outstand82.99M Perf Week2.79%
Market Cap39.00B Forward P/E42.51 EPS next Y11.08 Insider Trans-13.56% Shs Float82.01M Perf Month-1.67%
Income699.20M PEG3.63 EPS next Q2.47 Inst Own91.80% Short Float / Ratio2.70% / 5.70 Perf Quarter-3.52%
Sales3.43B P/S11.37 EPS this Y-6.70% Inst Trans-0.23% Short Interest2.21M Perf Half Y10.56%
Book/sh10.13 P/B46.48 EPS next Y14.26% ROA25.90% Target Price559.67 Perf Year27.38%
Cash/sh1.34 P/C350.08 EPS next 5Y15.60% ROE117.40% 52W Range317.06 - 515.79 Perf YTD15.41%
Dividend- P/FCF85.58 EPS past 5Y19.60% ROI36.70% 52W High-8.72% Beta1.19
Dividend %- Quick Ratio0.70 Sales past 5Y11.30% Gross Margin59.70% 52W Low48.50% ATR12.27
Employees10780 Current Ratio1.10 Sales Q/Q7.60% Oper. Margin27.10% RSI (14)46.04 Volatility2.45% 2.41%
OptionableYes Debt/Eq1.43 EPS Q/Q12.50% Profit Margin20.40% Rel Volume0.99 Prev Close469.84
ShortableYes LT Debt/Eq0.83 EarningsMay 02 BMO Payout0.00% Avg Volume387.97K Price470.83
Recom2.20 SMA20-1.60% SMA50-2.31% SMA2009.63% Volume384,155 Change0.21%
Date Action Analyst Rating Change Price Target Change
Jul-25-22Downgrade Stifel Buy → Hold $415
Jul-21-22Upgrade Goldman Neutral → Buy $530 → $435
Jul-12-22Initiated Piper Sandler Overweight $440
May-05-22Downgrade BofA Securities Buy → Neutral $550 → $470
Feb-08-22Initiated Atlantic Equities Overweight $650
Nov-18-21Initiated Morgan Stanley Overweight
Aug-05-21Resumed Credit Suisse Outperform $735
Jul-12-21Downgrade Guggenheim Buy → Neutral
Feb-17-21Initiated Barclays Overweight $600
Sep-09-19Initiated Goldman Neutral $277
Jun-01-23 11:31AM
May-29-23 06:14AM
May-23-23 07:50PM
May-22-23 08:00AM
May-17-23 09:00AM
09:15AM Loading…
May-10-23 09:15AM
May-06-23 09:00AM
May-03-23 06:25AM
May-02-23 11:09PM
10:07AM Loading…
Apr-28-23 10:07AM
Apr-27-23 12:49PM
Apr-26-23 08:00PM
Apr-25-23 10:56AM
Apr-24-23 02:35PM
Apr-22-23 07:00AM
Apr-21-23 11:28AM
Apr-20-23 10:41AM
Apr-18-23 11:32AM
Apr-14-23 09:00AM
Apr-13-23 03:00PM
11:40AM Loading…
Apr-12-23 11:40AM
Apr-10-23 11:00AM
Apr-06-23 07:00AM
Mar-31-23 07:35AM
Mar-18-23 08:00AM
Mar-14-23 10:01AM
Mar-08-23 11:40AM
Mar-06-23 07:00AM
Feb-28-23 11:12AM
Feb-27-23 09:38AM
Feb-24-23 03:13AM
Feb-23-23 10:27AM
Feb-21-23 04:05PM
Feb-20-23 11:40AM
Feb-16-23 06:01AM
Feb-13-23 11:05PM
Feb-12-23 07:00AM
Feb-10-23 09:45AM
Feb-08-23 09:00AM
Feb-07-23 02:38PM
Feb-06-23 04:33PM
Feb-04-23 06:00AM
Feb-03-23 08:30AM
Feb-02-23 10:00AM
Feb-01-23 05:00AM
Jan-31-23 11:40AM
Jan-26-23 08:15AM
Jan-25-23 10:35AM
Jan-23-23 09:30AM
Jan-18-23 08:30AM
Jan-17-23 12:10PM
Jan-13-23 11:10AM
Jan-12-23 07:01AM
Jan-10-23 07:15PM
Jan-09-23 02:37PM
Jan-08-23 06:00AM
Jan-04-23 06:01AM
Dec-26-22 06:10AM
Dec-22-22 02:35PM
Dec-15-22 09:25AM
Dec-14-22 10:28AM
Dec-12-22 05:55AM
Dec-07-22 11:41AM
Dec-02-22 11:31AM
Nov-08-22 05:55AM
Nov-01-22 06:29PM
Oct-31-22 11:35AM
Oct-26-22 10:01AM
Oct-25-22 10:01AM
Oct-19-22 12:35PM
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AYERS JONATHAN WDirectorMay 19Option Exercise79.5410,000795,400147,039May 22 05:00 PM
AYERS JONATHAN WDirectorMay 19Sale491.3510,0004,913,502137,039May 22 05:00 PM
AYERS JONATHAN WDirectorMay 18Option Exercise79.5410,000795,400147,039May 22 05:00 PM
AYERS JONATHAN WDirectorMay 18Sale489.2310,0004,892,268137,039May 22 05:00 PM
SZOSTAK M ANNEDirectorMay 11Option Exercise0.0034401,604May 15 05:32 PM
Vandebroek Sophie V.DirectorMay 11Option Exercise0.0034401,216May 15 05:32 PM
COLLINS AshaDirectorMay 11Option Exercise0.003440522May 15 05:31 PM
ESSIG STUARTDirectorMay 11Option Exercise0.0034401,717May 15 05:31 PM
Kingsley Lawrence DDirectorMay 11Option Exercise0.0046408,544May 15 05:32 PM
AYERS JONATHAN WDirectorMay 11Option Exercise0.003440140,553May 15 05:31 PM
AYERS JONATHAN WDirectorMay 10Option Exercise178.2656099,826141,894May 11 05:01 PM
Underberg Sharon E.EVP, GC & Corporate SecretaryMay 05Option Exercise206.9448399,9524,245May 08 05:04 PM
MCKEON BRIAN PEVP, CFO and TreasurerMay 05Option Exercise178.2656099,82629,605May 08 05:02 PM
SZOSTAK M ANNEDirectorMay 05Sale474.892,000949,7894,700May 08 05:03 PM
Lane MichaelExecutive Vice PresidentMay 05Sale484.001,000484,0004,022May 08 05:01 PM
Vandebroek Sophie V.DirectorMay 04Option Exercise206.622,187451,8783,059May 05 06:01 PM
MAZELSKY JONATHAN JAYPresident and CEOMay 04Option Exercise178.2656099,82673,301May 05 06:00 PM
Vandebroek Sophie V.DirectorMay 04Sale469.022,1871,025,740872May 05 06:01 PM
JUNIUS DANIEL MDirectorFeb 16Option Exercise206.622,187451,8785,169Feb 17 05:06 PM
Turner Kathy VSenior Vice PresidentFeb 16Option Exercise79.54107957,390Feb 17 05:04 PM
JUNIUS DANIEL MDirectorFeb 16Sale511.682,1871,119,0442,982Feb 17 05:06 PM
Turner Kathy VSenior Vice PresidentFeb 16Sale515.58105,1567,380Feb 17 05:04 PM
Turner Kathy VSenior Vice PresidentFeb 15Sale510.031,000510,0317,380Feb 17 05:04 PM
Turner Kathy VSenior Vice PresidentFeb 14Option Exercise58.232,732159,0809,380Feb 16 06:56 PM
POLEWACZYK JAMES FExecutive Vice PresidentFeb 14Option Exercise0.00834016,605Feb 16 06:54 PM
Smith Martin AlexanderExecutive Vice PresidentFeb 14Option Exercise0.001490227Feb 16 06:55 PM
MCKEON BRIAN PExecutive VP & CFOFeb 14Option Exercise0.001,928030,239Feb 16 06:53 PM
MAZELSKY JONATHAN JAYPresident & CEOFeb 14Option Exercise0.003,561074,384Feb 16 06:52 PM
Hunt NimrataExecutive Vice PresidentFeb 14Option Exercise0.00791011,254Feb 16 06:51 PM
Lane MichaelExecutive Vice PresidentFeb 14Option Exercise0.0091505,282Feb 16 06:51 PM
Underberg Sharon E.EVP, GC & Corp. SecretaryFeb 14Option Exercise0.001,01004,052Feb 16 06:56 PM
Turner Kathy VSenior Vice PresidentFeb 14Sale504.592,0001,009,1897,380Feb 16 06:56 PM
Hunt NimrataExecutive Vice PresidentFeb 09Option Exercise141.6070699,97010,463Feb 10 05:00 PM
Turner Kathy VSenior Vice PresidentFeb 09Option Exercise79.541,00079,5407,941Feb 13 05:01 PM
Turner Kathy VSenior Vice PresidentFeb 09Sale505.041,000505,0376,941Feb 13 05:01 PM
JUNIUS DANIEL MDirectorDec 05Option Exercise160.283,046488,2136,014Dec 07 04:30 PM
JUNIUS DANIEL MDirectorDec 05Sale424.913,0461,294,2762,968Dec 07 04:30 PM
SZOSTAK M ANNEDirectorDec 02Option Exercise160.282,000320,5602,000Dec 06 05:01 PM
SZOSTAK M ANNEDirectorDec 02Sale428.55740317,1271,260Dec 06 05:01 PM
Turner Kathy VSenior Vice PresidentDec 01Option Exercise141.603,000424,8009,923Dec 05 05:00 PM
Turner Kathy VSenior Vice PresidentDec 01Sale436.003,0001,308,0006,923Dec 05 05:00 PM
MAZELSKY JONATHAN JAYPresident & CEONov 14Option Exercise62.0018,9981,177,87681,305Nov 16 05:00 PM
MAZELSKY JONATHAN JAYPresident & CEONov 14Sale434.4710,5004,561,91270,805Nov 16 05:00 PM
Turner Kathy VSenior Vice PresidentNov 11Option Exercise178.268,5671,527,15315,490Nov 14 05:00 PM
Turner Kathy VSenior Vice PresidentNov 11Sale438.538,5673,756,9216,923Nov 14 05:00 PM
Turner Kathy VSenior Vice PresidentNov 10Option Exercise206.945,3101,098,85112,233Nov 14 05:00 PM
Turner Kathy VSenior Vice PresidentNov 10Sale407.625,3102,164,4606,923Nov 14 05:00 PM
MAZELSKY JONATHAN JAYPresident & CEONov 07Option Exercise52.0024,0021,248,10475,537Nov 09 05:00 PM
MAZELSKY JONATHAN JAYPresident & CEONov 07Sale382.4913,2305,060,31962,307Nov 09 05:00 PM
Smith Martin AlexanderExecutive Vice PresidentSep 01Option Exercise0.0019049Sep 06 05:00 PM
MAZELSKY JONATHAN JAYPresident & CEOAug 05Option Exercise0.00385051,697Aug 08 05:00 PM
MCKEON BRIAN PExecutive VP & CFOAug 05Option Exercise0.00192028,366Aug 08 05:01 PM